Single subcutaneous injection of 20 mg of adalimumab, a biologic TNF-blocker

Official descriptor: Adalimumab injection

Injection, adalimumab, 20 mg

Effective 1/1/2005Terminated 12/31/2024

Inactive since December 31, 2024

This code is no longer billable. Claims with this code will be denied for dates of service after the inactive date.

No automated successor mapping is available. Consult the CMS transmittal or AMA CPT Assistant for replacement guidance.

AIClinical Context

Clinical Description

This code represents the administration of adalimumab, a tumor necrosis factor (TNF) blocker, in a 20 mg dose. Adalimumab is a biologic medication used to treat various autoimmune and inflammatory conditions by reducing inflammation and suppressing the immune system.

When to Use

Use this code when documenting the subcutaneous injection of 20 mg of adalimumab for conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, or juvenile idiopathic arthritis. Documentation should clearly specify the drug name, dosage (20 mg), and route of administration (injection).

Coding Tips

Ensure the medical record explicitly states a 20 mg dose was administered; do not extrapolate from other dosages.

Same Category

J0013Esketamine, nasal spray J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius

+5 more in this category

Code History

Added in FY2024
Inactive since FY2026

This code is no longer billable. Check the replacement code if applicable.

Change History

FY2026 snapshotAdalimumab injection
FY2025 snapshotAdalimumab injection
FY2024 snapshotAdalimumab injection